Latigo launches with $135 million for Vertex

DesmondPadhi,PharmD,interimCEO,Latigo(center),withLatigoboardchairNancyStagliano(left)andWestlakeVil AdobeFindinganewmedicineisnevereasy.Butdevelopingtreatmentsforpatientswithrarediseases—conditionstha




focus

author：focus    Page View：2956

Editor’s note: A livestream of the event will be embedded below at 1 p.m. ET.

STAT’s reporters, strung-out from several days of ASCO madness, will take the virtual stage to share convention hall insights, predictions for the months ahead, and of course will take your audience questions live.

advertisement

Sponsor Introduction

  • Ashwin Athri, EVP, strategy, innovation, & partnerships, Precision AQ

Featured Speakers

  • Angus Chen, cancer reporter, STAT
  • Adam Feuerstein, senior writer, biotech, STAT
  • Matthew Herper, senior writer, medicine; editorial director of events, STAT
  • Katherine MacPhail, programmer, editorial events, STAT (moderator)

Sponsored By

Previous article： GSK to buy asthma
Next article： Virginia high school admissions case could be legal follow